[1]
K. J. SREE, R. MUDHULKAR, S. GUNDEKARI, N. K. KOTTAKKI, and A. S. KONDURI, “QBD-BASED RP-UPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ATEZOLIZUMAB AND HYALURONIDASE IN CANCER DRUG FORMULATIONS”, Int J App Pharm, vol. 17, no. 5, pp. 406–416, Sep. 2025.